Addendum: A phase II trial of cytoreductive surgery combined with niraparib maintenance in platinum-sensitive, secondary recurrent ovarian cancer: SGOG SOC-3 study.

ABSTRACT:

SUBMITTER: Shi T 

PROVIDER: S-EPMC9250854 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature